{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:57Z","timestamp":1791823737029,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Circular RNAs (circRNAs) play crucial roles in cancer progression and metastasis. However, the expression profiles and biological roles of circRNAs in non-small cell lung cancer (NSCLC) remain unclear. In this study, we found a novel circRNA, hsa_circ_0001936(circBRWD3), in NSCLC and investigated the biological role of circBRWD3 in NSCLC progression in vitro and in vivo. qRT-PCR was used to quantify the expression of circBRWD3 in NSCLC tissues, serum and cells. Cell growth curves, colony formation, Edu assay and transwell assays were conducted to study the function of circBRWD3. Finally, the molecular mechanism of circBRWD3 was revealed by Bioinformatic analyses, RNA pull-down analysis, RNA Fluorescence in situ hybridization (FISH), RNA-Binding Protein Immunoprecipitation (RIP), western blot, dual-luciferase reporter gene assays and rescue experiments. Our results showed that circBRWD3 was upregulated in NSCLC tumor tissues, patient serum and cell lines. CircBRWD3 knockdown inhibited NSCLC cells\u2019 growth and metastasis both in vitro and in vivo, while circBRWD3 overexpression had the opposite effect. Mechanistically, circBRWD3 binds to the TRIM25 protein to enhance its stability and mediate ubiquitin degradation of the p53 protein. In addition, circBRWD3 acted as a sponge for miR-135a-5p and miR-135b-5p to regulate the expression of SPTBN2, which promoted NSCLC progression. Our findings uncovered a tumor oncogenic function of circBRWD3 in NSCLC through the regulation of TRIM25 protein stability and miR-135a-5p\/miR-135b-5p\/SPTBN2 axis. CircBRWD3 may act as a promising oncogenic biomarker and therapeutic target for NSCLC.<\/jats:p>","DOI":"10.1038\/s41419-026-09103-3","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:13:40Z","timestamp":1784207620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircBRWD3 promotes non-small cell lung cancer progression through enhancing the stability of TRIM25 to increase p53 ubiquitin degradation and upregulating SPTBN2"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-2862","authenticated-orcid":false,"given":"Yanhua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-8064","authenticated-orcid":false,"given":"Yuefeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2840-4807","authenticated-orcid":false,"given":"Mei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2379-2483","authenticated-orcid":false,"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7573-8937","authenticated-orcid":false,"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5616-5770","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6168-661X","authenticated-orcid":false,"given":"Jiezhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1507-4631","authenticated-orcid":false,"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7075-9341","authenticated-orcid":false,"given":"Yanliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"9103_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"9103_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, et al. Non-small cell lung cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2024;22:249\u201374.","journal-title":"J Natl Compr Cancer Netw"},{"key":"9103_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LEL Hendriks","year":"2024","unstructured":"Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2024;10:71.","journal-title":"Nat Rev Dis Primers"},{"key":"9103_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02038-3","volume":"23","author":"M Wang","year":"2024","unstructured":"Wang M, Ding X, Fang X, Xu J, Chen Y, Qian Y, et al. Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p\/TXNIP axis. Mol Cancer. 2024;23:128.","journal-title":"Mol Cancer"},{"key":"9103_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19:188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"key":"9103_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-023-02657-6","volume":"42","author":"J Wei","year":"2023","unstructured":"Wei J, Li M, Xue C, Chen S, Zheng L, Deng H, et al. Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. J Exp Clin Cancer Res. 2023;42:86.","journal-title":"J Exp Clin Cancer Res"},{"key":"9103_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13046-023-02916-6","volume":"42","author":"Y Yao","year":"2023","unstructured":"Yao Y, Chen C, Wang J, Xuan H, Chen X, Li Z, et al. Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization. J Exp Clin Cancer Res. 2023;42:330.","journal-title":"J Exp Clin Cancer Res"},{"key":"9103_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01998-w","volume":"23","author":"YF Tang","year":"2024","unstructured":"Tang YF, Liu ZH, Zhang LY, Shi SH, Xu S, Ma JA, et al. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p\/ IGF1R pathway in non-small cell lung cancer (NSCLC). Mol Cancer. 2024;23:91.","journal-title":"Mol Cancer"},{"key":"9103_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01888-7","volume":"22","author":"Y Cui","year":"2023","unstructured":"Cui Y, Wu X, Jin J, Man W, Li J, Li X, et al. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis. Mol Cancer. 2023;22:179.","journal-title":"Mol Cancer"},{"key":"9103_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/tox.22980","volume":"35","author":"Z Fan","year":"2020","unstructured":"Fan Z, Bai Y, Zhang Q, Qian P. CircRNA circ_POLA2 promotes lung cancer cell stemness via regulating the miR-326\/GNB1 axis. Environ Toxicol. 2020;35:1146\u201356.","journal-title":"Environ Toxicol"},{"key":"9103_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295.","journal-title":"Nat Commun"},{"key":"9103_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01595-9","volume":"21","author":"J Hua","year":"2022","unstructured":"Hua J, Wang X, Ma L, Li J, Cao G, Zhang S, et al. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p\/IGF1R\/AKT axis. Mol Cancer. 2022;21:123.","journal-title":"Mol Cancer"},{"key":"9103_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13046-023-02791-1","volume":"42","author":"D Zhao","year":"2023","unstructured":"Zhao D, Dong Y, Duan M, He D, Xie Q, Peng W, et al. Circadian gene ARNTL initiates circGUCY1A2 transcription to suppress non-small cell lung cancer progression via miR-200c-3p\/PTEN signaling. J Exp Clin Cancer Res. 2023;42:229.","journal-title":"J Exp Clin Cancer Res"},{"key":"9103_CR14","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.cell.2022.06.001","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell. 2022;185:2390.","journal-title":"Cell"},{"key":"9103_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01606-9","volume":"21","author":"X Zang","year":"2022","unstructured":"Zang X, Jiang J, Gu J, Chen Y, Wang M, Zhang Y, et al. Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of beta-catenin by promoting delta-catenin ubiquitin degradation and upregulating SIK1. Mol Cancer. 2022;21:141.","journal-title":"Mol Cancer"},{"key":"9103_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/cac2.12380","volume":"43","author":"Y Yang","year":"2023","unstructured":"Yang Y, Luo D, Shao Y, Shan Z, Liu Q, Weng J, et al. circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer. Cancer Commun. 2023;43:100\u201322.","journal-title":"Cancer Commun"},{"key":"9103_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105.","journal-title":"Mol Cancer"},{"key":"9103_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01912-w","volume":"23","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q, et al. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis. Mol Cancer. 2024;23:4.","journal-title":"Mol Cancer"},{"key":"9103_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01582-0","volume":"21","author":"C Xue","year":"2022","unstructured":"Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, et al. The functional roles of the circRNA\/Wnt axis in cancer. Mol Cancer. 2022;21:108.","journal-title":"Mol Cancer"},{"key":"9103_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5306\/wjco.v12.i8.646","volume":"12","author":"AC Tecalco-Cruz","year":"2021","unstructured":"Tecalco-Cruz AC, Abraham-Juarez MJ, Solleiro-Villavicencio H, Ramirez-Jarquin JO. TRIM25: A central factor in breast cancer. World J Clin Oncol. 2021;12:646\u201355.","journal-title":"World J Clin Oncol"},{"key":"9103_CR21","first-page":"1","volume":"50","author":"JM Lee","year":"2018","unstructured":"Lee JM, Choi SS, Lee YH, Khim KW, Yoon S, Kim BG, et al. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARgamma. Exp Mol Med. 2018;50:1\u201311.","journal-title":"Exp Mol Med"},{"key":"9103_CR22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","volume":"29","author":"H Xie","year":"2022","unstructured":"Xie H, Yao J, Wang Y, Ni B. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis. Drug Deliv. 2022;29:1257\u201371.","journal-title":"Drug Deliv"},{"key":"9103_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/etm.2023.11977","volume":"25","author":"L Yang","year":"2023","unstructured":"Yang L, Gu Y. SPTBN2 regulates endometroid ovarian cancer cell proliferation, invasion and migration via ITGB4\u2011mediated focal adhesion and ECM receptor signalling pathway. Exp Ther Med. 2023;25:277.","journal-title":"Exp Ther Med"},{"key":"9103_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103039","volume":"70","author":"J Deng","year":"2024","unstructured":"Deng J, Lin X, Qin J, Li Q, Zhang Y, Zhang Q, et al. SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization. Redox Biol. 2024;70:103039.","journal-title":"Redox Biol"},{"key":"9103_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24:597\u2013613.","journal-title":"Nat Rev Cancer"},{"key":"9103_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01957-5","volume":"23","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Jia Y, Wang J, Chen X, Han J, Zhen S, et al. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP\/IL-6 axis. Mol Cancer. 2024;23:47.","journal-title":"Mol Cancer"},{"key":"9103_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, et al. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22:55.","journal-title":"Mol Cancer"},{"key":"9103_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2024","unstructured":"Huang D, Zhu X, Ye S, Zhang J, Liao J, Zhang N, et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature. 2024;625:593\u2013602.","journal-title":"Nature"},{"key":"9103_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23:49.","journal-title":"Mol Cancer"},{"key":"9103_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02090-z","volume":"23","author":"Z Sun","year":"2024","unstructured":"Sun Z, Xu Y, Si C, Wu X, Guo Y, Chen C, et al. Targeting m7G-enriched circKDM1A prevents colorectal cancer progression. Mol Cancer. 2024;23:179.","journal-title":"Mol Cancer"},{"key":"9103_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10200-7","volume":"22","author":"X Meng","year":"2022","unstructured":"Meng X, Li W, Meng Z, Li Y. EIF4A3-induced circBRWD3 promotes tumorigenesis of breast cancer through miR-142-3p_miR-142-5p\/RAC1\/PAK1 signaling. BMC Cancer. 2022;22:1225.","journal-title":"BMC Cancer"},{"key":"9103_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05423-0","volume":"22","author":"H Xu","year":"2024","unstructured":"Xu H, Zheng Y, Wu J, Zhang R, Zhao Q, Chen S, et al. circSORBS1 inhibits lung cancer progression by sponging miR-6779-5p and directly binding RUFY3 mRNA. J Transl Med. 2024;22:590.","journal-title":"J Transl Med"},{"key":"9103_CR33","volume":"2022","author":"X Liu","year":"2022","unstructured":"Liu X, Chen Z, Wu Y, Gu F, Yan D, Yang L, et al. Circ_0078767 inhibits the progression of non-small-cell lung cancer by regulating the GPX3 expression by adsorbing miR-665. Int J Genom. 2022;2022:6361256.","journal-title":"Int J Genom"},{"key":"9103_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05881-2","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Luo J, Yang W, Ye WC. CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets. Cell Death Dis. 2023;14:353.","journal-title":"Cell Death Dis"},{"key":"9103_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01607-8","volume":"21","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen S, Liu R, Chen H, Xu B, Xu W, et al. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway. Mol Cancer. 2022;21:146.","journal-title":"Mol Cancer"},{"key":"9103_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s11658-025-00779-7","volume":"30","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Han J, Pan Y, Liu Y, Zhang Z, Chen H, et al. Ribosomal protein RPL7A modulates lung adenocarcinoma progression via circRANBP17-UPF1-mediated SIRT6 degradation. Cell Mol Biol Lett. 2025;30:145.","journal-title":"Cell Mol Biol Lett"},{"key":"9103_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06395-5","volume":"23","author":"L Wu","year":"2025","unstructured":"Wu L, Gu L, Zheng Y, Liu J, Wei Z, Liu F, et al. CircPRKCA facilitates esophageal squamous cell carcinoma metastasis via m5C-dependent CSF2 mRNA stabilization. J Transl Med. 2025;23:385.","journal-title":"J Transl Med"},{"key":"9103_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04235-y","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang F, Ma Q, Huang B, Wang X, Pan X, Yu T, et al. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med. 2023;21:402.","journal-title":"J Transl Med"},{"key":"9103_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01471-y","volume":"21","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang K, Tan S, Gao F, Zhang Y, Xu W, et al. Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3-eIF3h interaction. Mol Cancer. 2022;21:49.","journal-title":"Mol Cancer"},{"key":"9103_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357.","journal-title":"Cancer Lett"},{"key":"9103_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang G, Liang M, Liu H, Huang J, Li P, Wang C, et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/beta-catenin pathway. Cell Death Dis. 2020;11:1065.","journal-title":"Cell Death Dis"},{"key":"9103_CR42","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/ijbs.58916","volume":"17","author":"B Fu","year":"2021","unstructured":"Fu B, Liu W, Zhu C, Li P, Wang L, Pan L, et al. Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis. Int J Biol Sci. 2021;17:3104\u201317.","journal-title":"Int J Biol Sci"},{"key":"9103_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02760-6","volume":"22","author":"Y Fei","year":"2024","unstructured":"Fei Y, Cao D, Li Y, Wang Z, Dong R, Zhu M, et al. Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer. J Nanobiotechnology. 2024;22:519.","journal-title":"J Nanobiotechnology"},{"key":"9103_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.684866","volume":"8","author":"R Zhang","year":"2021","unstructured":"Zhang R, Zhu W, Ma C, Ai K. Silencing of circRNA circ_0001666 represses EMT in pancreatic cancer through upregulating miR-1251 and downregulating SOX4. Front Mol Biosci. 2021;8:684866.","journal-title":"Front Mol Biosci"},{"key":"9103_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s11658-025-00814-7","volume":"30","author":"K Chen","year":"2025","unstructured":"Chen K, Pan X, Zhang S, Xu M, Chen X, Pei F, et al. Circular RNA circSLC39A10 promotes prostate cancer progression by activating Wnt signaling via the miR-936\/PROX1\/beta-catenin axis. Cell Mol Biol Lett. 2025;30:126.","journal-title":"Cell Mol Biol Lett"},{"key":"9103_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02359-z","volume":"30","author":"W Chen","year":"2025","unstructured":"Chen W, Fang S, Wu X, Fang T, Chen Z, Su W, et al. circZNF707 promoted glycolysis and tumor progression through miR-668-3p-PFKM axis in NSCLC. Eur J Med Res. 2025;30:141.","journal-title":"Eur J Med Res"},{"key":"9103_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10142-023-01157-2","volume":"23","author":"KX Zhang","year":"2023","unstructured":"Zhang KX, Ding C, Liu QH, Zhu DM. Knockdown of LINC01087 inhibits gastric cancer malignant behavior by regulating the miR-135a-5p\/CAAP1 axis. Funct Integr Genom. 2023;23:248.","journal-title":"Funct Integr Genom"},{"key":"9103_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05286-5","volume":"22","author":"M Wang","year":"2024","unstructured":"Wang M, Niu X, Wang M, Zheng P, Liu X, Cao Z, et al. Long non-coding RNA RP11-197K6.1 as ceRNA promotes colorectal cancer progression via miR-135a-5p\/DLX5 axis. J Transl Med. 2024;22:469.","journal-title":"J Transl Med"},{"key":"9103_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114623","volume":"155","author":"HX Gao","year":"2025","unstructured":"Gao HX, Liu MH, Fan M, Zhou JJ, Li AQ, Chen MW. MiR-135a-5p\/STAT6-mediated EMT regulates IL-4 secretion in non-small cell lung cancer to affect M2-like TAM polarization. Int Immunopharmacol. 2025;155:114623.","journal-title":"Int Immunopharmacol"},{"key":"9103_CR50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/mmr.2021.12167","volume":"24","author":"H Diao","year":"2021","unstructured":"Diao H, Xu X, Zhao B, Yang G. miR\u2011135a\u20115p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer. Mol Med Rep. 2021;24:528","journal-title":"Mol Med Rep"},{"key":"9103_CR51","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.7150\/thno.59546","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Wu Y, Luo X, Jin D, Zhou W, Ju Z, et al. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer. Theranostics. 2021;11:7507\u201326.","journal-title":"Theranostics"},{"key":"9103_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00530-4","volume":"11","author":"J Zhang","year":"2023","unstructured":"Zhang J, Luo Q, Li X, Guo J, Zhu Q, Lu X, et al. Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA\/NKG2D pathway. Biomark Res. 2023;11:86.","journal-title":"Biomark Res"},{"key":"9103_CR53","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/cvr\/cvae162","volume":"120","author":"J Tan","year":"2024","unstructured":"Tan J, Min J, Jiang Y, Liu S, Ke M, Wang Z, et al. CircCHSY1 protects hearts against ischaemia\/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p. Cardiovasc Res. 2024;120:1924\u201338.","journal-title":"Cardiovasc Res"},{"key":"9103_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01409-4","volume":"20","author":"Y Mo","year":"2021","unstructured":"Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20:112.","journal-title":"Mol Cancer"},{"key":"9103_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, Shen Y, Wu D, Zhang J, Lin C, Wang L, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022;21:145.","journal-title":"Mol Cancer"},{"key":"9103_CR56","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41420-021-00776-7","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang P, Liu T, Zhao Z, Wang Z, Liu S, Yang X. SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4\/PI3K\/AKT axis. Cell Death Discov. 2021;7:382.","journal-title":"Cell Death Discov"},{"key":"9103_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.687576","volume":"8","author":"P Feng","year":"2021","unstructured":"Feng P, Ge Z, Guo Z, Lin L, Yu Q. A Comprehensive analysis of the downregulation of miRNA-1827 and its prognostic significance by targeting SPTBN2 and BCL2L1 in ovarian cancer. Front Mol Biosci. 2021;8:687576.","journal-title":"Front Mol Biosci"},{"key":"9103_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2562595","volume":"2022","author":"X Zhou","year":"2022","unstructured":"Zhou X, Lin L, Qi Y, Xu M, Xu Q, Wang Y, et al. SPTBN2 promotes the progression of thyroid cancer by accelerating G1\/S transition and inhibiting apoptosis. Dis Markers. 2022;2022:2562595.","journal-title":"Dis Markers"},{"key":"9103_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jare.2025.01.021","volume":"77","author":"Y Cui","year":"2025","unstructured":"Cui Y, Liu J, Wang X, Wu Y, Chang Y, Hu X, et al. Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment. J Adv Res. 2025;77:721\u201332.","journal-title":"J Adv Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09103-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:19Z","timestamp":1791821119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9103"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09103-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The sample collection was approved by the Ethics Committee of the First Affiliated Hospital of Kunming Medical University (ethics approval number: [2022] Ethics L No. 222).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"878"}}